Basal Cell Carcinoma
Basal cell carcinoma is the second most common form of skin cancer in immunosuppressed transplant recipients. This is different than for the general population in which basal cell carcinoma is the most common. The risk for basal cell carcinoma is 10 times that of the general population.
It appears as a small, pink, pearly bump or patch that can ulcerate, bleed, or crust repeatedly. It occurs predominately on skin surfaces that have been exposed repeatedly to the sun such as the head and neck, but it may occur on any skin surface. It is slow growing and rarely spreads to other parts of the body. If left untreated, it can lead to extensive damage and destruction of the skin and underlying structures involved.
Treatment of basal cell carcinoma may consist of electrodesiccation and curettage, surgical excision, or Mohs surgery. Radiation may also be an optional treatment. Recommended treatment depends on the characteristics of the tumor and the patient.
Note: Please click on the thumbnails below to display a larger image.
Your tax-deductible donation supports the education and research of physicians and scientists committed to improving the quality of life of organ transplant recipients. If you are unable to donate online or require other information to make a gift through a trust or other source, email firstname.lastname@example.org for additional assistance. ITSCC's federal tax ID is 43-1964114.
ITSCC is a nonprofit 501(c)(3) organization, and has received support through unrestricted educational grants from pharmaceutical companies and donations of time and funds from physicians, researchers, transplant patients and their families.